ABL1 and leukemia: In this study we used a mouse model of bone marrow transplantation (BMT) for BCR-ABL driven leukemia and observed that loss of Egr1 in BCR-ABL expressing bone marrow (BM) accelerated the onset of myeloid leukemia.